 CUPERTINO, Calif., Feb. 2, 2021 PRNewswire -- DURECT Corporation Nasdaq: DRRX today announced that the U.S. Food and Drug Administration FDA has approved POSIMIR bupivacaine solution for infiltration use in adults for administration into the subacromial space under direct... 